Clinical Trial: A Clinical Study GK01 Cell Injection in Subjects With Advanced Lung Cancer

U.S., June 30 -- ClinicalTrials.gov registry received information related to the study (NCT07673419) titled 'A Clinical Study GK01 Cell Injection in Subjects With Advanced Lung Cancer' on June 23.

Brief Summary: A Single-Arm, Open-Label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of GK01 Cell Injection in Participants with Advanced Lung Cancer

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Advanced Lung Cancer

Intervention: DRUG: GK01 Injection

Autologous tumor-reactive T cells injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Beijing Geekgene Technology Co., LTD

Published by HT Digital Content Services with permission from Health Daily Digest....